secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lantern Pharma Inc. (LTRN)
CIK:        0001763950
Form:       8-K
Filed at:   2026-10-01T20:01:23+00:00
Accession:  0001493152-26-045344
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Lantern Pharma gets Nasdaq notice: MVLS under $35M for 30 days, 180 days to regain compliance
--------------------------------------------------------------------------------

- Nasdaq notice dated September 25, 2026: market value of listed securities (MVLS) fell below the $35,000,000 minimum for 30 consecutive business days.
- Company also does not meet Nasdaq Listing Rules 5550(b)(1) and 5550(b)(3), per the notice.
- Has until March 24, 2027 (180 calendar days) to regain compliance under Listing Rule 5810(c)(3)(C).
- To cure via MVLS, LTRN stock must close at $35,000,000 or more for a minimum of 10 consecutive business days.
- If compliance is not regained, the company expects Nasdaq to notify it that its securities are subject to delisting from the Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226045344/0001493152-26-045344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1763950/000149315226045344/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-045344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer